pHion Therapeutics

pHion Therapeutics is a UK based biotech delivering ground-breaking nucleic acid vaccines and therapeutics. The proprietary RALA peptide-based drug delivery system is based on a sequence of 30 amino acids which condenses anionic cargo (RNA and DNA), irrespective of size, into nanoparticles. These nanoparticles are highly efficient at cellular entry with 100% release from the endosomes. When used in vaccines, the RALA platform can deliver multiple anionic molecules, such as mRNA, in a stealth-like way by evading detection. This generates both a potent antigen-specific CD8+ T-cell response that is ideal for therapeutic vaccines, and a long-term T-Cell and antibody memory...

Drug delivery,formulation,oncology,nucleic acid therapeutics,antimicrobial,peptide chemistry,mrna,vaccines,infectious disease,immunotherapy,chemotherapy,therapeutic vaccine,and prophylactic vaccines

Phion therapeutics operates in the Biotechnology industry.

Phion therapeutics's revenue is 11m - 100m

Phion therapeutics has 11 - 50 employees.